CROCS, INC.
In the published model solve dated 2026-Q2, anchored at $117.53, CROCS, INC. (CROX) is priced for +1.7% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 25, 2026 from SEC EDGAR filings.
• Two brands, two very different trajectories: Crocs Brand revenue edged up 0.8% to 767 million dollars in the March 2026 quarter while HEYDUDE fell 12.3% to 154 million, and the gap between them is the whole investment question [Source: Q1 2026 earnings release, April 30, 2026]. • Profitability is not the problem: the quarter produced income from operations of 200.8 million dollars on 921.5 million of revenue, a 21.8% operating margin, with gross margin at 56.8% [Source: Q1 2026 Form 10-Q]. • T
Is CROX overvalued? See what's priced in →
442 institutional managers reported holding CROX in 13F filings for the quarter ended 2026-03-31. Together they hold about 94% of the company; the top 10 hold 47%. 65 opened new positions that quarter. Held by BlackRock, Vanguard Group, FMR (Fidelity), among others. On the short side, 5.5M shares were sold short as of the 2026-06-15 count, about 11% of shares outstanding (4.4 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
CROX has cut its share count 22.2% over the past five years, spending $1.96B on repurchases. It pays no dividend. Cash returned over the past three years: $1.31B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at CROX over the trailing three years: 2023: 7 buys totaling $1.81M; 2024: 4 buys totaling $849k; 2025: 4 buys totaling $627k. 17 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
CROX's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-28 | -9.7% | -18.4% |
| 2023-11-03 | -4.0% | +3.0% |
| 2024-02-16 | +9.8% | +1.3% |
| 2024-05-08 | +6.9% | +3.5% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
CROX's latest 8-K filings: 2026-07-30 (items 2.02, 8.01, 9.01); 2026-06-10 (items 5.02, 5.07, 9.01); 2026-04-30 (items 2.02, 9.01); 2026-02-12 (items 2.02, 9.01); 2025-10-30 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.